Press release
Europe Biobanking Market Trends, Share, Size, Outlook, Growth, Segments & Forecast | 2024 - 2032
Europe Biobanking Market
What is Biobanking?
Biobanks are large collections of biological samples, such as blood, tissue, urine, and DNA, which are used in scientific research. These biological materials play a vital role in helping researchers understand various diseases and develop new treatments. Biobanks can either be population-based or disease-specific and are essential for personalised medicine, clinical trials, and genomic studies.
The function of biobanks extends beyond the mere storage of biological samples. They act as repositories for data, which help scientists study genetic mutations, disease progression, and individual responses to treatments. This also facilitates drug development, vaccine research, and the exploration of personalised medicine.
Get a Free Sample Report with Table of Contents: https://tinyurl.com/26whmclu
Market Size, Growth, and Outlook
The global biobanking market was valued at USD 72.1 billion in 2023 and is expected to grow at a CAGR of 6.89% during the forecast period of 2024 to 2032. By 2032, the market is anticipated to reach USD 131.1 billion. This growth can be attributed to a combination of factors, including advancements in medical research, government support, the increasing prevalence of chronic diseases, and the rising demand for personalised healthcare solutions.
Europe currently holds a dominant position in the biobanking market, largely driven by the presence of major research institutions, robust healthcare infrastructure, and favourable regulatory environments. However, regions such as North America, Asia Pacific, and the Middle East are expected to see significant growth in the coming years, driven by the expansion of research capabilities and technological advancements.
Key Market Drivers
Increasing Biomedical Research Investment: The increasing focus on biomedical research is one of the primary drivers of market growth. As nations invest more in healthcare research, the demand for biobanks to store biological samples grows. Biobanks offer a critical resource for researchers and pharmaceutical companies looking to understand diseases and develop new drugs.
Technological Advancements: With the advent of advanced technologies such as next-generation sequencing (NGS) and artificial intelligence (AI), the role of biobanks has expanded. These technologies allow for the rapid analysis of genetic data, making biobanks a valuable tool for researchers working in genomics, molecular biology, and drug development.
Personalised Medicine and Clinical Trials: As the healthcare sector shifts towards personalised medicine, the demand for biobanks is expected to rise. Biobanks provide the resources needed for genomic research, which is crucial for tailoring treatments to individual genetic profiles. This is particularly important for drug discovery and clinical trials.
Government Support and Regulations: Governments across the globe are recognising the importance of biobanks in healthcare and are providing funding and regulatory support. These initiatives are helping drive the growth of the biobanking market by improving access to high-quality biological samples for research purposes.
Read Full Report with Table of Contents: https://tinyurl.com/25lyukbk
Key Players in the Biobanking Market
Thermo Fisher Scientific Inc. Based in Waltham, Massachusetts, Thermo Fisher Scientific is a global leader in scientific research, offering a broad range of products and services for the biobanking sector. The company provides sample collection, preservation, and storage solutions that cater to research institutions, hospitals, and pharmaceutical companies.
Qiagen N.V. Based in Hilden, Germany, Qiagen is a prominent player in the biobanking market, offering technologies for sample storage, purification, and analysis. The company's products help researchers in genomics, oncology, and molecular diagnostics.
VWR International (Avantor) Avantor, based in Radnor, Pennsylvania, is a global provider of laboratory and production supplies. The company offers a range of biobanking products, including sample collection and storage solutions, to support research in genomics and biotechnology.
BioCision LLC Headquartered in San Rafael, California, BioCision specialises in sample storage and handling solutions for biobanks. Their products help maintain sample integrity during collection, transportation, and storage, ensuring reliable results in research.
China National Biotech Group (CNBG) CNBG, based in Beijing, is one of the leading biotech companies in China. They have invested heavily in biobanking technologies, especially in relation to clinical research and drug discovery. The company is focused on expanding its biobank network to enhance precision medicine research.
Reprogenetics Ltd. Based in the United Kingdom, Reprogenetics is a key player in the field of human genetics and reproductive health. The company offers genetic testing services and partners with various biobanks for the collection of samples related to fertility and genetic conditions.
Market Segmentation
The biobanking market can be segmented based on type, application, and geography:
By Type:
Population-based Biobanks: These are repositories of biological samples from a large group of individuals representing a diverse population. They are used to study genetic variations across different ethnic groups and how they relate to disease prevalence.
Disease-specific Biobanks: These biobanks focus on samples from individuals with specific diseases. They are used for studying the genetic basis of particular illnesses such as cancer, diabetes, and cardiovascular diseases.
By Application:
Research and Development: Biobanks play a critical role in supporting research activities, particularly in genomics, molecular biology, and pharmacogenomics. They provide invaluable resources for the development of new treatments, drugs, and vaccines.
Clinical Trials: Biobanks support clinical trials by providing genetic and biological material to study how individuals respond to treatments. This is vital for developing personalised therapies.
By Geography:
North America: With advanced healthcare infrastructure and substantial funding for research, North America is a dominant player in the biobanking market.
Europe: The European region holds a significant share in the market due to the presence of numerous research institutions and favourable regulatory environments.
Asia-Pacific: This region is expected to experience the fastest growth in the biobanking market, driven by growing healthcare investments and expanding research capabilities.
Trends Shaping the Biobanking Market
Integration of Artificial Intelligence and Machine Learning: AI and machine learning are transforming how biobank data is analysed. These technologies are used to identify patterns in genetic data, predict disease outcomes, and optimise sample storage and management.
Advances in Genomic Research: As genomic research continues to grow, biobanks are becoming increasingly important. The rise of next-generation sequencing and CRISPR technology has opened new avenues for studying genetic diseases, with biobanks providing the necessary samples.
Increasing Demand for Stem Cell and Regenerative Medicine: Stem cells and regenerative medicine are rapidly gaining importance in the field of healthcare. Biobanks are becoming critical in storing stem cells for use in research and therapies related to regenerative medicine.
Personalised Medicine and Targeted Therapies: The growing emphasis on personalised medicine has led to an increase in the need for specific genetic data. Biobanks that provide samples from diverse populations are instrumental in identifying genetic markers for diseases and personalising treatments.
COVID-19 Impact on the Biobanking Market
The COVID-19 pandemic had a significant impact on the biobanking market, both in terms of challenges and opportunities. On one hand, the disruption caused by the pandemic led to delays in sample collection and processing due to lockdowns and social distancing measures. On the other hand, the increased focus on virus research has underscored the importance of biobanks in the development of vaccines and treatments. The demand for biobank resources surged, particularly for COVID-19-related studies.
As the world recovers from the pandemic, biobanks are expected to play an even more critical role in future research, particularly in the study of emerging infectious diseases.
FAQs
What are biobanks used for?
Biobanks are used to store biological samples for research purposes, helping scientists study genetics, disease progression, and drug development.
How do biobanks contribute to healthcare?
Biobanks enable personalised medicine by providing researchers with the necessary data to understand how genetics influence health and disease, allowing for the development of targeted treatments.
What types of biological samples are stored in biobanks?
Biobanks store a wide variety of biological samples, including blood, saliva, urine, tissues, and DNA.
How are biobanks regulated?
Biobanks are subject to strict ethical and legal regulations to ensure the privacy and security of the biological samples and data they store.
What is the future outlook for the biobanking market?
The biobanking market is expected to grow significantly due to increasing investments in biomedical research, technological advancements, and the rise of personalised medicine.
Market Share and Growth Forecast
The biobanking market is growing steadily, with Europe currently holding the largest share. North America is a strong competitor, but the Asia-Pacific region is anticipated to experience rapid growth, driven by increasing healthcare investments and research activities.
The market's growth is supported by the rising demand for genomic research, the expansion of clinical trials, and the increasing need for personalised healthcare solutions. With the forecasted CAGR of 6.89% from 2024 to 2032, the global biobanking market is set to see substantial growth in the coming years.
As we look ahead, the market is poised for continued development, with key trends such as the integration of AI, advances in genomic research, and a growing emphasis on personalised medicine further driving its expansion.
Related Trending Reports
Global Medical Adhesives Market : https://tinyurl.com/2d38zfwr
Global Biologics Market : https://tinyurl.com/2cqgrsng
Global Dental Implants Market : https://tinyurl.com/2cdxvppa
Global Dental Consumables Market : https://tinyurl.com/2af6b2lb
Media Contact :
Company Name: Claight Corporation
Contact Person: James william, Corporate Sales Specialist
Email: sales@expertmarketresearch.com
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analysis provides the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today's competitive market.
Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organisation's future success by acquiring one of our Expert Market Research reports today.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Europe Biobanking Market Trends, Share, Size, Outlook, Growth, Segments & Forecast | 2024 - 2032 here
News-ID: 3782073 • Views: …
More Releases from Expert Market Research
Bed and Bath Linen Market Trends, Growth & Forecast 2025-2034
The global bed and bath linen market is witnessing strong growth due to increasing consumer focus on home décor, comfort, and luxury. Rising disposable incomes, urbanization, and the booming hospitality sector are further boosting demand for premium-quality bed sheets, pillowcases, towels, and bathrobes. Technological innovations in fabrics, such as antimicrobial, wrinkle-resistant, and sustainable textiles, are shaping consumer preferences. In addition, the expansion of online distribution channels has made luxury and…
Global Fruit Juice Market Size, Report and Forecast 2025-2034
The latest report from Expert Market Research titled, "Global Fruit Juice Market Size, Report and Forecast 2025-2034," offers a comprehensive analysis of the global fruit juice market, examining it across various segments such as types, flavours, distribution channels, and key regions.
The report identifies and tracks the latest trends shaping the industry and evaluates their impact on the overall market dynamics. It also provides a thorough assessment of the market, covering…
Global Fluorspar Market Forecast 2025-2034: Growth, Trends, and Key Insights
According to the latest report by Expert Market Research (EMR), the global Fluorspar Market Size is projected to grow at a CAGR of 5.60% between 2025 and 2034. The market is expected to experience significant growth by 2034, driven by the increasing demand for fluorspar across industries such as manufacturing, chemicals, and metallurgy.
Fluorspar, also known as fluorite, is a key industrial mineral composed of calcium fluoride (CaF2). It is crucial…
Why will smart pulse oximeters market hit $3.50Bn by 2034?
smart pulse oximeters market Overview
The smart pulse oximeters market has become a pivotal part of modern healthcare infrastructure, especially in the wake of increasing cardiovascular and respiratory ailments. These technologically enhanced devices measure blood oxygen saturation and pulse rate, often offering wireless connectivity to mobile apps for better health tracking. Their growing application in hospitals, ambulatory settings, and home healthcare environments reflects the market's evolving dynamics. Key drivers include the…
More Releases for Biobanks
Biobanks Market Demand, Survey, Forecast 2028
According to Premium Market Insights new research study on "biobanks market is projected to reach US$ 3,758.64 million by 2028 from US$ 2,418.31 million in 2021; it is expected to grow at a CAGR of 6.5% during 2021-2028.
Get a Sample Copy of This Report@ https://www.premiummarketinsights.com/sample/TIP00073331/?utm_source=OpenPR&utm_medium=10655
Some Of the Major Players Influencing are THERMO FISHER SCIENTIFIC INC., Tecan Trading AG, QIAGEN, Hamilton Company, Avantor, Inc., MICRONICS JAPAN CO., LTD., BD, Taylor-Wharton, Brooks…
Electronic Health Records (EHR) To Catalyse The Biobanks Market
Biobanks refers to the repository that collects, stores and distributes human biological materials including blood, plasma, saliva, purified DNA and other biospecimens. Biological banks keep a record of personal and health related information such as genetic information, health records, lifestyle, and family history for use it in health and medical research.
Biological materials are stored in biobanks in an appropriate environment. It helps to detect human diseases and their causes; by…
South America Biobanks Market Growth Factors, Opportunities, Ongoing Trends
The biobanks market in South America is expected to grow from US$ 190.08 million in 2021 to US$ 261.23 million by 2028; it is estimated to grow at a CAGR of 4.6% from 2021 to 2028.
South America Biobanks Market study by "The Business Market Insights" provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive…
Biobanks Market - Product Growth Strategies 2025 | BioCision, Tecan Group
Global Biobanks Market: Snapshot
Biobanks are essentially repositories for storing biological substances derived from humans, which may include organs, bio-specimens, plasma, saliva, and blood. With a vast rise in the number of organ replacement surgeries globally and significant advancements made in the fields of transfusion and replacement technologies, the role of the biobanks market has become more concrete in the healthcare sector in recent years.
The global biobanks market has witnessed expansion…
Biobanks Market Explores New Growth Opportunities By 2020
Biobanks refers to the repository that collects, stores and distributes human biological materials including blood, plasma, saliva, purified DNA and other biospecimens. Biological banks keep a record of personal and health related information such as genetic information, health records, lifestyle, and family history for use it in health and medical research. Biological materials are stored in biobanks in an appropriate environment.
To view complete report @ http://www.persistencemarketresearch.com/market-research/biobanks-market.asp
It helps to detect human…
Biobanks Market: Industry Survey and Outlook 2025
Global Biobanks Market: Overview
The global biobanks market owes its conception to the rising need for replacement organs and the steady advancement in the replacement and transfusion technologies regarding a number of bodily substances. Though the technology and need to store organs and other bio-entities had been available for a long time, the global biobanks market took on a more important role in the healthcare sector following the increasing research in…
